COCRYSTAL PHARMA INC COCP
ASignal's systematic analysis rates COCP as Bearish.
Reflects the latest available analysis · analyzed Nov 13, 2026
The case on COCP
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Price near lower Bollinger Band suggesting potential reversal
- Positive MACD histogram indicating slight momentum improvement
- Cash position exceeds total debt providing runway
- Negative price momentum and trading below key moving averages (SMA20, SMA50)
- Extremely weak fundamentals: negative operating margin (-3063.64%) and negative ROE (-311.68%)
- Elevated valuation metrics: PB (13.03x), PS (57.79x), EV/Revenue (55.28x)
- Negative EV/EBITDA (-1.81x) indicating unprofitability
- Negative free cash flow (-$4.32M) and operating cash flow (-$7.95M)
- No news coverage or Reddit mentions indicating low market sentiment
See the full verdict on COCP
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes COCP
Most investors never get a second opinion, let alone several. ASignal runs COCP past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.